EBRZF(EBRZF)
EBRZF
No analyst ratings available
No analyst price targets available for EBRZF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $66.63B | $64.69B | $67.16B | $63.87B | $64.90B |
| Low | $56.25B | $56.43B | $57.65B | $54.83B | $55.72B |
| High | $74.47B | $71.99B | $74.90B | $71.23B | $72.39B |
| EBITDA Avg | $19.83B | $19.25B | $19.99B | $19.01B | $19.32B |
| Low | $16.74B | $16.80B | $17.16B | $16.32B | $16.58B |
| High | $22.17B | $21.43B | $22.29B | $21.20B | $21.55B |
| EBIT Avg | $13.82B | $13.42B | $13.93B | $13.24B | $13.46B |
| Low | $11.67B | $11.70B | $11.96B | $11.37B | $11.55B |
| High | $15.44B | $14.93B | $15.53B | $14.77B | $15.01B |
| Net Income Avg | $6.33B | $6.96B | $7.61B | $7.26B | $7.58B |
| Low | $5.17B | $5.68B | $6.21B | $5.93B | $6.19B |
| High | $7.28B | $8.00B | $8.75B | $8.35B | $8.72B |
| EPS Avg | $2.90 | $3.18 | $3.48 | $3.32 | $3.47 |
| Low | $2.36 | $2.60 | $2.84 | $2.71 | $2.83 |
| High | $3.33 | $3.66 | $4.00 | $3.82 | $3.99 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $10.37B | $13.00B | $14.12B | $8.34B | $7.47B | $9.13B | $9.52B | $8.65B |
| Low | $10.37B | $13.00B | $14.12B | $8.34B | $7.47B | $9.13B | $9.52B | $8.65B |
| High | $10.37B | $13.00B | $14.12B | $8.34B | $7.47B | $9.13B | $9.52B | $8.65B |
| EBITDA Avg | $3.09B | $3.87B | $4.20B | $2.48B | $2.22B | $2.72B | $2.83B | $2.57B |
| Low | $3.09B | $3.87B | $4.20B | $2.48B | $2.22B | $2.72B | $2.83B | $2.57B |
| High | $3.09B | $3.87B | $4.20B | $2.48B | $2.22B | $2.72B | $2.83B | $2.57B |
| EBIT Avg | $2.15B | $2.70B | $2.93B | $1.73B | $1.55B | $1.89B | $1.97B | $1.79B |
| Low | $2.15B | $2.70B | $2.93B | $1.73B | $1.55B | $1.89B | $1.97B | $1.79B |
| High | $2.15B | $2.70B | $2.93B | $1.73B | $1.55B | $1.89B | $1.97B | $1.79B |
| Net Income Avg | $1.20B | $1.87B | $2.19B | $1.38B | $1.22B | $1.79B | $2.58B | $1.66B |
| Low | $1.20B | $1.87B | $2.19B | $1.38B | $1.22B | $1.79B | $2.58B | $1.66B |
| High | $1.20B | $1.87B | $2.19B | $1.38B | $1.22B | $1.79B | $2.58B | $1.66B |
| EPS Avg | $0.55 | $0.85 | $1.00 | $0.63 | $0.56 | $0.82 | $1.18 | $0.76 |
| Low | $0.55 | $0.85 | $1.00 | $0.63 | $0.56 | $0.82 | $1.18 | $0.76 |
| High | $0.55 | $0.85 | $1.00 | $0.63 | $0.56 | $0.82 | $1.18 | $0.76 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |